SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-012065
Filing Date
2022-08-04
Accepted
2022-08-04 07:47:51
Documents
86
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20220630x10q.htm   iXBRL 10-Q 2162794
2 EX-31.1 tmb-20220630xex31d1.htm EX-31.1 10599
3 EX-31.2 tmb-20220630xex31d2.htm EX-31.2 10613
4 EX-32.1 tmb-20220630xex32d1.htm EX-32.1 8328
  Complete submission text file 0001558370-22-012065.txt   8852613

Data Files

Seq Description Document Type Size
5 EX-101.SCH tmb-20220630.xsd EX-101.SCH 79843
6 EX-101.CAL tmb-20220630_cal.xml EX-101.CAL 51546
7 EX-101.DEF tmb-20220630_def.xml EX-101.DEF 364216
8 EX-101.LAB tmb-20220630_lab.xml EX-101.LAB 560292
9 EX-101.PRE tmb-20220630_pre.xml EX-101.PRE 514005
80 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220630x10q_htm.xml XML 1430399
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39801 | Film No.: 221134747
SIC: 2834 Pharmaceutical Preparations